{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:15:42Z","timestamp":1788984942189,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijantimicag.2023.107074","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T11:21:48Z","timestamp":1703589708000},"page":"107074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["HIV drug resistance among patients experiencing antiretroviral therapy failure in Russia, 2019\u20132021"],"prefix":"10.1016","volume":"63","author":[{"given":"Mariya V.","family":"Sivay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4273-1704","authenticated-orcid":false,"given":"Lada V.","family":"Maksimenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana M.","family":"Nalimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya A.","family":"Nefedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina P.","family":"Osipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-3391","authenticated-orcid":false,"given":"Nadezda P.","family":"Kriklivaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya P.","family":"Gashnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0465-1260","authenticated-orcid":false,"given":"Vasiliy E.","family":"Ekushov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7418-4872","authenticated-orcid":false,"given":"Alexei V.","family":"Totmenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7060-4710","authenticated-orcid":false,"given":"Dmitriy V.","family":"Kapustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa L.","family":"Pozdnyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey E.","family":"Skudarnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana S.","family":"Ostapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana V.","family":"Yaschenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga I.","family":"Nazarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery V.","family":"Shevchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Ilyina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Novikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander P.","family":"Agafonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0891-0880","authenticated-orcid":false,"given":"Natalya M.","family":"Gashnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijantimicag.2023.107074_bib0001","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jmv.20177","article-title":"Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A","volume":"74","author":"Bobkov","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0002","unstructured":"Central Research Institute of Epidemiology, Federal service on customers' rights protection and human well-being surveillance. hiv statistics in russian federation. 2023. http:\/\/www.hivrussia.info\/wp-content\/uploads\/2023\/09\/Spravka-VICH-v-Rossii-na-31.12.2022.pdf. [accessed 15.10.23]."},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0003","unstructured":"State strategy to combat the spread of HIV in Russia through 2020 and beyond. 2016. Ministry of Health of Russian Federation. http:\/\/government.ru\/docs\/24983\/. [accessed 21.08.22]."},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0004","unstructured":"Ministry if Health of Russian Federation. 2020 Clinical recommendations. HIV infection in children. http:\/\/rushiv.ru\/wp-content\/uploads\/2021\/05\/KR-459-1.pdf [accessed 15.09.22]."},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0005","unstructured":"Ministry if Health of Russian Federation. 2020 Clinical recommendations. HIV infection in adults. http:\/\/rushiv.ru\/wp-content\/uploads\/2020\/06\/KR79-ot-21.04.20.pdf [accessed 15.09.22]."},{"issue":"2","key":"10.1016\/j.ijantimicag.2023.107074_bib0006","first-page":"75","article-title":"Prevalence and structure of HIV-1 drug resistance among treatment na\u00efve patients since the introduction of antiretroviral therapy in the Russian Federation","volume":"11","author":"Kirichenko","year":"2019","journal-title":"HIV Infect Immunosuppr Disord"},{"issue":"1","key":"10.1016\/j.ijantimicag.2023.107074_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257731","article-title":"Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries","volume":"17","author":"Kirichenko","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0008","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18565\/therapy.2022.3.35-41","article-title":"Analysis of prevalence of HIV-1 antiretroviral drug resistance among ART-na\u00efve patients in Novosibirsk region","volume":"3","author":"Kapustin","year":"2022","journal-title":"Therapy"},{"issue":"1","key":"10.1016\/j.ijantimicag.2023.107074_bib0009","doi-asserted-by":"crossref","first-page":"28","DOI":"10.36233\/0372-9311-216","article-title":"Genetic diversity and drug resistance mutations of HIV-1 in Leningrad region","volume":"99","author":"Shchemelev","year":"2022","journal-title":"J Microbiol Epidemiol Immunobiol"},{"issue":"1","key":"10.1016\/j.ijantimicag.2023.107074_bib0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.36233\/0372-9311-178","article-title":"Subtype diversity, phylogenetic analysis, and drug resistance analysis of HIV-1 circulating in Ural Federal District","volume":"99","author":"Piterskiy","year":"2022","journal-title":"J Microbiol Epidemiol Immunobiol"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0011","unstructured":"UNAIDS data 2022. The Joint United Nations Programme on HIV\/AIDS. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/data-book-2022_en.pdf [accessed 29.10.23]."},{"issue":"5","key":"10.1016\/j.ijantimicag.2023.107074_bib0012","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","article-title":"IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era","volume":"37","author":"Minh","year":"2020","journal-title":"Mol biol evol"},{"issue":"1","key":"10.1016\/j.ijantimicag.2023.107074_bib0013","first-page":"47","article-title":"Genetic analysis of HIV-1 in the Altai Kray: the further spread of the CRF63_02A1 variant in Western Siberia","volume":"12","author":"Kazennova","year":"2020","journal-title":"HIV Infect Immunosuppr Disord"},{"issue":"9","key":"10.1016\/j.ijantimicag.2023.107074_bib0014","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/aid.2020.0225","article-title":"Genetic diversity and drug resistance mutations in reverse transcriptase and protease genes of HIV-1 Isolates from Southwestern Siberia","volume":"37","author":"Rudometova","year":"2021","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"10.1016\/j.ijantimicag.2023.107074_bib0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/pathogens10030264","article-title":"HIV drug resistance mutations detection by next-generation sequencing during antiretroviral therapy interruption in China","volume":"10","author":"Li","year":"2021","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.ijantimicag.2023.107074_bib0016","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/cid\/ciab583","article-title":"Transmitted drug resistance among human immunodeficiency virus (HIV)-1 diagnoses in the United States, 2014\u20132018","volume":"74","author":"McClung","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ijantimicag.2023.107074_bib0017","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/jac\/dks310","article-title":"Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting","volume":"67","author":"Maiga","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.ijantimicag.2023.107074_bib0018","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/01.aids.0000131358.29586.6b","article-title":"Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy","volume":"18","author":"Kantor","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0019","article-title":"The need for pediatric formulations to treat children with HIV","volume":"2016","author":"Schlatter","year":"2016","journal-title":"AIDS Res Treat"},{"issue":"9","key":"10.1016\/j.ijantimicag.2023.107074_bib0020","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11633630-000000000-00000","article-title":"HIV-1 antiretroviral resistance: scientific principles and clinical applications","volume":"72","author":"Tang","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0021","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10461-012-0319-6","article-title":"Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment","volume":"17","author":"Gonzalez","year":"2013","journal-title":"AIDS Behav"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00002030-200401001-00004","article-title":"Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse","volume":"18","author":"Hinkin","year":"2004","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.ijantimicag.2023.107074_bib0023","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/QAI.0b013e3181684c3d","article-title":"Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with men","volume":"47","author":"Gorbach","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0024","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.aids.0000131310.52526.c7","article-title":"The prevalence of antiretroviral drug resistance in the United States","volume":"18","author":"Richman","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0025","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1001\/jama.279.24.1984","article-title":"Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society\u2013USA Panel","volume":"279","author":"Hirsch","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0026","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/427192","article-title":"Predictors of HIV drug-resistance mutations in a large antiretroviral-na\u00efve cohort initiating triple antiretroviral therapy","volume":"191","author":"Harrigan","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ijantimicag.2023.107074_bib0027","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1097\/INF.0b013e31827f44ee","article-title":"Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants","volume":"32","author":"Fogel","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.ijantimicag.2023.107074_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209605","article-title":"Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter study cohort","volume":"14","author":"Machnowska","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijantimicag.2023.107074_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12981-020-0258-7","article-title":"Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda","volume":"17","author":"Ayitewala","year":"2020","journal-title":"AIDS Res Ther"},{"issue":"6","key":"10.1016\/j.ijantimicag.2023.107074_bib0030","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/650748","article-title":"High genetic barrier antiretroviral drugs in human immunodeficiency virus\u2013positive pregnancy","volume":"50","author":"Zazzi","year":"2010","journal-title":"Clin Infec Dis"},{"issue":"37","key":"10.1016\/j.ijantimicag.2023.107074_bib0031","doi-asserted-by":"crossref","first-page":"e21661","DOI":"10.1097\/MD.0000000000021661","article-title":"High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia","volume":"99","author":"Jordan","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ijantimicag.2023.107074_bib0032","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/hiv.12109","article-title":"Unplanned antiretroviral treatment interruptions, genetic barrier, and development of resistance","volume":"15","author":"Llibre","year":"2014","journal-title":"HIV Med."},{"issue":"10","key":"10.1016\/j.ijantimicag.2023.107074_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258930","article-title":"Determinants of first-line antiretroviral treatment failure among adult patients on treatment in Mettu Karl Specialized Hospital, South West Ethiopia; a case control study","volume":"16","author":"Zenu","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0034","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12879-020-05177-2","article-title":"Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study","volume":"20","author":"Agegnehu","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.ijantimicag.2023.107074_bib0035","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2352-3018(22)00160-6","article-title":"Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicenter, randomized, noninferiority ODYSSEY trial","volume":"9","author":"Turkova","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijantimicag.2023.107074_bib0036","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11904-020-00502-5","article-title":"Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions","volume":"17","author":"Spinelli","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"8","key":"10.1016\/j.ijantimicag.2023.107074_bib0037","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s10461-018-2379-8","article-title":"Use of antiretroviral drug testing to assess the accuracy of self-reported data from HIV-infected people who inject drugs","volume":"23","author":"Fogel","year":"2019","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.ijantimicag.2023.107074_bib0038","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10461-018-2231-1","article-title":"Accuracy of self-reported HIV status among African men and transgender women who have sex with men who were screened for participation in a research study: HPTN 075","volume":"23","author":"Fogel","year":"2019","journal-title":"AIDS Behav"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923003631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923003631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:47:58Z","timestamp":1760377678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923003631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0924857923003631"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107074","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV drug resistance among patients experiencing antiretroviral therapy failure in Russia, 2019\u20132021","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107074"}}